RS

Rohan Shriram Patil

Active Director Designated Partner DIN 09430170
DIN 09430170 First appointment Dec 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rohan Shriram Patil

Data last updated:

Rohan Shriram Patil is a Designated Partner at 99 Clinic Multispeciality Hospital Llp (since 2021). The company operates in Healthcare.

DIN 09430170
Primary Designation Designated Partner
Industry Healthcare
First Appointment 09 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Dec 20212021Active

Board colleagues of Rohan Shriram Patil

Directorship timeline

Open interactive timeline →
99 Clinic Multispeciality Hospital Llp
Premium access

Shareholding and investment profile for Rohan Shriram Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohan Shriram Patil

Rohan Shriram Patil currently holds 1 directorship: 99 Clinic Multispeciality Hospital Llp (Designated Partner, since 09 Dec 2021).

Rohan Shriram Patil was first appointed on 09 Dec 2021 as Designated Partner at 99 Clinic Multispeciality Hospital Llp.

The current boards of Rohan Shriram Patil's companies include Rushiraj Pawan Pande (99 Clinic Multispeciality Hospital Llp), Snehal Mahaveerkumar Badjate (99 Clinic Multispeciality Hospital Llp), Vaibhav Rameshrao Bedarkar (99 Clinic Multispeciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available